Detalhe da pesquisa
1.
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Lancet
; 401(10373): 294-302, 2023 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709074
2.
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.
Lancet
; 393(10174): 889-898, 2019 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30686586
3.
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.
JAMA
; 323(14): 1369-1377, 2020 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286643
4.
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.
N Engl J Med
; 366(14): 1275-86, 2012 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22475592
5.
HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.
Immunogenetics
; 66(5): 299-310, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24682434
6.
Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.
J Infect Dis
; 207(12): 1829-40, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23482645
7.
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
J Infect Dis
; 207(8): 1195-205, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22837492
8.
Genetic immunization in the lung induces potent local and systemic immune responses.
Proc Natl Acad Sci U S A
; 107(51): 22213-8, 2010 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21135247
9.
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials.
J Infect Dis
; 206(3): 431-41, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22634875
10.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis
; 23(12): 1408-1417, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37544326
11.
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.
Lancet Infect Dis
; 22(8): 1210-1220, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568049
12.
Ethical and scientific implications of the globalization of clinical research.
N Engl J Med
; 360(26): 2793; author reply 2793, 2009 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19557890
13.
Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-inserts.
Toxicol Sci
; 91(2): 620-30, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16569728
14.
Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts.
Toxicol Sci
; 91(2): 610-9, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16569729
15.
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens.
AIDS Res Hum Retroviruses
; 31(11): 1178-86, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26234467
16.
Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction.
Int J STD AIDS
; 14(7): 478-81, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12869229
17.
Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines.
Sci Transl Med
; 6(228): 228ra38, 2014 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24648341
18.
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection.
PLoS One
; 9(2): e87572, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24504509
19.
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial.
PLoS One
; 8(1): e53629, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23349725
20.
The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.
AIDS Res Hum Retroviruses
; 28(11): 1444-57, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23035746